Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Isis antisense compound and analogues covered by U.S. patent

Oct. 18, 1996

No Comments

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Oct. 18, 1996

No Comments

Natural antitumor indanone reported by Sagami

Oct. 18, 1996

No Comments

Eisai claims RXR agonists

Oct. 18, 1996

No Comments

New antitumor agents from Sagami

Oct. 18, 1996

No Comments

VCAM-1 inhibitors from Sagami

Oct. 18, 1996

No Comments

Banyu reports natural antitumor agent

Oct. 18, 1996

No Comments

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Oct. 18, 1996

No Comments

Broader role of VEGF in tumor growth proposed

Oct. 18, 1996

No Comments

Chemokine/cytokine combination effective for tumor therapy

Oct. 18, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cancer
RSS

Isis antisense compound and analogues covered by U.S. patent

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Natural antitumor indanone reported by Sagami

Eisai claims RXR agonists

New antitumor agents from Sagami

VCAM-1 inhibitors from Sagami

Banyu reports natural antitumor agent

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Broader role of VEGF in tumor growth proposed

Chemokine/cytokine combination effective for tumor therapy

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Medtronic receives CE mark for next generation Endoflip system

Cancer RSS

Cancer
RSS